Immediate Impact

1 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
3 intermediate papers

Works of Ron D. Jachimowicz being referenced

The bispecific immunoligand ULBP2‐aCEA redirects natural killer cells to tumor cells and reveals potent anti‐tumor activity against colon carcinoma
2013
Induction ofIn VitroandIn VivoNK Cell Cytotoxicity Using High-Avidity Immunoligands Targeting Prostate-Specific Membrane Antigen in Prostate Carcinoma
2011

Author Peers

Author Last Decade Papers Cites
Ron D. Jachimowicz 158 101 94 125 16 308
David Sermer 207 109 98 91 22 364
M Andreeff 132 88 134 97 14 367
Sarah Haebe 167 76 121 114 25 313
Federica Melle 125 86 132 62 18 269
Quanli Gao 219 76 61 107 13 312
Zsolt Zoltán Fülöp 82 120 101 142 17 320
Mary McCauley 127 57 58 94 13 299
Shereen Gheith 59 69 60 147 15 274
Chan‐Sik Park 129 39 134 149 14 326
Erik Hameister 136 54 65 101 11 280

All Works

Loading papers...

Rankless by CCL
2026